title: Spontaneous, nontraumatic gas gangrene due to Clostridium perfringens.
authors.forename: T
authors.initials: T
authors.lastname: Yildiz
authors.forename: S
authors.initials: S
authors.lastname: Gündeş
authors.forename: A
authors.initials: A
authors.lastname: Willke
authors.forename: M
authors.initials: M
authors.lastname: Solak
authors.forename: K
authors.initials: K
authors.lastname: Toker
mesh_terms: D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001768:Blister / Q000382:microbiology; D002442:Ceftazidime / Q000627:therapeutic use; D003016:Clostridium perfringens / Q000302:isolation & purification*; D016638:Critical Illness / Q000628:therapy; D017809:Fatal Outcome; D005738:Gas Gangrene / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D013281:Stomatitis, Aphthous / Q000382:microbiology / Q000473:pathology
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D008795:Metronidazole; D000583:Amikacin; D002442:Ceftazidime